Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as C$0.11 and last traded at C$0.11, with a volume of 289295 shares trading hands. The stock had previously closed at C$0.14.
Nanalysis Scientific Stock Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.10 and a current ratio of 1.42. The stock has a market cap of C$15.23 million, a PE ratio of -2.20 and a beta of -0.48. The firm has a fifty day moving average price of C$0.13 and a 200 day moving average price of C$0.14.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Featured Articles
- Five stocks we like better than Nanalysis Scientific
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
- Looking Beyond NVIDIA? These 3 AI ETFs Are Beating the Market
- Palantir’s Kool-Aid Moment: The Math Behind Karp’s Forecast
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
